Levosimendan Labatec 12.5 mg/5 ml, solution à diluer pour perfusion
7680695510010
CH-69551
Lösung
Associated product:
LEVOSIMENDAN Labatec conc perf 12.5 mg/5ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
levosimendanum
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
povidonum K 12
|
- | Substance | HNIDK |
|
ethanolum anhydricum
|
3.945 G | Substance | HBESI |
|
acidum citricum
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69551
- Drug name
- Levosimendan Labatec, solution à diluer pour perfusion
- Galenic form
- KOINF
- ATC Code
- C01CX08
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/07/2024
- Authorization expiration date
- 09/07/2029
- IT Number
- 02.05.2.
- Domain
- Human medicine
Package details
- Description (FR)
- LEVOSIMENDAN Labatec conc perf 12.5 mg/5ml flac
- Description (DE)
- LEVOSIMENDAN Labatec 12.5 mg/5ml Inf Konz Durchstf
- Market launch
- 21/04/2026
- Narcotic (BTM)
- No